Estimating disease risk using genetic data
Award amount
$241,905Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- 23ANDME, INC.
- Proposal award date
- 2017-04-14
- Contract end date
- 2019-03-31
- UEI
- JUVFHKN9XCY3
- Solicitation number
- PA15-269
- Topic code
- 172
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Admixture-driven discovery of disease-associated genetic variants not found in Europeans
- A new reference panel to boost African American genotype imputation
- Development of a web-based database and research engine for genetic discovery
- Development of DNA Sequence Data-Quality Metrics for Personal Genomics
- Development of a web-based database and research engine for genetic discovery
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DNA-optical barcoding technology for spatiotemporal single-cell analysis
- CRISPR-based depletion method for resolving pseudogene contamination in Next Generation Sequencing (NGS) based genetic testing
- Pioneering assays for spatially-resolved single-cell multiomics
- A Novel Instrument and Consumables for Quality Control in Next Generation Sequencing
- Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding kinetics
Research funding history
8 SBIR/STTR records share this UEI (2010–2017). Reported award amounts total $4,391,423. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II, Phase II
Agencies: Department of Health and Human Services